The national DBS brain tissue network pilot study: need for more tissue and more standardization

Area of Science:

• Neuroscience
• Neurology
• Medical Research

Background:

• Deep Brain Stimulation (DBS) is a widely used therapeutic intervention, with over 70,000 devices implanted globally.
• A significant limitation in advancing DBS research is the scarcity of well-characterized post-mortem brain tissue samples available to scientists.
• Understanding the long-term effects and mechanisms of DBS requires comprehensive data linked to tissue pathology.

Purpose of the Study:

• To establish a national Deep Brain Stimulation-Brain Tissue Network (DBS-BTN) to address the paucity of post-mortem DBS brain samples.
• To create a comprehensive database of clinical, imaging, and pathological data for DBS brain tissue.
• To make DBS brain tissue samples accessible to the research community to enhance the understanding of DBS and related brain circuitry.

Main Methods:

• Development of standard operating procedures for processing DBS brains.
• Collection of 19 DBS brains from 11 U.S. centers, with detailed clinical, imaging, and pathological data.
• Analysis of neuropathological findings and perilead responses to DBS in the collected cohort.

Main Results:

• A pilot study successfully collected and characterized DBS brain tissue, demonstrating the feasibility of the DBS-BTN.
• Data completeness was a challenge, with approximately 25% of data fields missing in the initial cohort.
• Neuropathological findings revealed discrepancies between clinical and pathological diagnoses in 16.7% of cases.

Conclusions:

• The establishment of the DBS-BTN is a feasible and valuable resource for the scientific community.
• Future efforts will focus on improving data completeness, expanding the donor pool, and enhancing sample preparation for molecular studies.
• The DBS-BTN has the potential to significantly advance the understanding of DBS mechanisms, brain function, and neurological diseases.